Citation: | Please cite this article as: Shin B, Li D, LIU H. Aortic valve leaflet disruption techniques in transcatheter aortic valve replacement. J Geriatr Cardiol 2022; 19(12): 990−994. DOI: 10.11909/j.issn.1671-5411.2022.12.006 |
[1] |
Cerrato E, Nombela-Franco L, Nazif TM, et al. Evaluation of current practices in transcatheter aortic valve implantation: the WRITTEN (WoRldwIde TAVI ExperieNce) survey. Int J Cardiol 2017; 228: 640−647. doi: 10.1016/j.ijcard.2016.11.104
|
[2] |
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187−2198. doi: 10.1056/NEJMoa1103510
|
[3] |
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374: 1609−1620. doi: 10.1056/NEJMoa1514616
|
[4] |
Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380: 1695−1705. doi: 10.1056/NEJMoa1814052
|
[5] |
Bonow RO, Brown AS, Gillam LD, et al. ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for the treatment of patients with severe aortic stenosis: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 70: 2566−2598. doi: 10.1016/j.jacc.2017.09.018
|
[6] |
Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med 2019; 6: 168. doi: 10.3389/fcvm.2019.00168
|
[7] |
Vandvik PO, Otto CM, Siemieniuk RA, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ 2016; 354: i5085. doi: 10.1136/bmj.i5085
|
[8] |
Ribeiro HB, Sarmento-Leite R, Siqueira DA, et al. Coronary obstruction following transcatheter aortic valve implantation. Arq Bras Cardiol 2014; 102: 93−96. doi: 10.5935/abc.20130252
|
[9] |
Kukucka M, Pasic M, Dreysse S, et al. Delayed subtotal coronary obstruction after transapical aortic valve implantation. Interact Cardiovasc Thorac Surg 2011; 12: 57−60. doi: 10.1510/icvts.2010.252866
|
[10] |
Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013; 62: 1552−1562. doi: 10.1016/j.jacc.2013.07.040
|
[11] |
Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J 2018; 39: 687−695. doi: 10.1093/eurheartj/ehx455
|
[12] |
Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv 2015; 8: e002079. doi: 10.1161/CIRCINTERVENTIONS.114.002079
|
[13] |
Khan JM, Greenbaum AB, Babaliaros VC, et al. BASILICA trial: one-year outcomes of transcatheter electrosurgical leaflet laceration to prevent TAVR coronary obstruction. Circ Cardiovasc Interv 2021; 14: e010238. doi: 10.1161/CIRCINTERVENTIONS.120.010238
|
[14] |
Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA. JACC Cardiovasc Interv 2019; 12: 1197−1216. doi: 10.1016/j.jcin.2019.04.052
|
[15] |
Khan JM, Dvir D, Greenbaum AB, et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human. JACC Cardiovasc Interv 2018; 11: 677−689. doi: 10.1016/j.jcin.2018.01.247
|
[16] |
Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv 2019; 12: 1240−1252. doi: 10.1016/j.jcin.2019.03.035
|
[17] |
Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry. JACC Cardiovasc Interv 2021; 14: 941−948. doi: 10.1016/j.jcin.2021.02.035
|
[18] |
Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol 2020; 76: 2492−2516. doi: 10.1016/j.jacc.2020.09.595
|